mix revenu miss though op margin ep benefit item
expect revenu guidanc cut mainli due china ep op
margin guidanc reiter updat key growth driver encourag
said like need build confid china issu truli transitori target
still achiev reiter market perform
revenu y/i report y/i organ
consensu estim forecast manag note organ
revenu growth within accordingli organ revenu growth
expect consensu segment da primarili driver miss
da organ revenu growth expect weak da perform
partial off-set strong diagnost organ revenu growth beat expect
grew healthi manag attribut da shortfal china
appli end market global industri end market weak
gross margin y/i consensu expect despit
gross margin miss expect oper margin y/i
line expect strong sg expens control off-set gross margin weak
ep y/i line expect guidanc howev adjust
higher expect non-oper expens lower expect tax rate
lower expect share count ep would
manag cut organ revenu growth guidanc reduct
primarili driven short-term uncertainti china appli market though softer
global industri end also contribut extent segment da expect
grow organ msd diagnost organ revenu growth
guidanc hsd reiter full year ep guidanc reiter
despit includ increment fx headwind full year oper margin expans
guidanc also reiter though gross margin expect
expand previous expans revenu guid
organ prior consensu ep guid consensu
net incom convers reduc
shortfal full year revenu guidanc reduct disappoint
guidanc assumpt emb prudent level conservat absent increment
sound confid still hit organ revenu growth margin target
hsd respect said believ confid need build
target order stock multipl reflect outlook remain impress
progress view risk/reward rel balanc
pleas see page report import disclosur
past year increas invest made sever portfolio chang
divestitur acquisit launch number new product action
appear bear fruit believ risk/reward get interest confid
build outlook msd core revenu growth growth euroimmun
ep trend slightli ahead expect
revenu growth acceler
beyond
deploy strategi ep
balanc invest growth area
hsd
deploy strategi ep
ou growth demonstr potenti
revenu growth limit
margin improv come short
provid divers array product servic address
diagnost research environment industri laboratori servic market report
two busi segment discoveri analyt solut diagnost
compani report thomson eikon cowen compani
cowen vs consensu mm except organ fx cisbio gross north op margin expans primarili driven gross margin oper margin expans like fx select revenu metric mm except analyt currenc growth growth currenc growth organ growth statement mm except expens forecast pre-tax per count rate forecast ep y/i line expect guidanc howev adjust higher expect non-oper expens lower expect tax rate lower expect share count ep would expect streetaccount consensu organ da revenu consensu estim forecast organ revenu growth expect manag attribut shortfal china appli end market global industri end market weak growth expect acceler rel level entir clear us conserv current junctur streetaccount consensu organ diagnost revenu expect organ revenu growth better expect euroimmun grew robust y/i organ manag commentari key busi within diagnost posit importantli vanadi placement track plan streetaccount consensu organ revenu y/i report y/i organ consensu estim forecast adjust round estim organ revenu growth expect segment da primarili driver miss da organ revenu growth expect weak da perform partial off-set strong diagnost organ revenu growth beat expect grew healthi manag attribut da shortfal china appli end market global industri end market weak gross margin y/i consensu expect manag note strong euroimmun instrument quarter neg impact gross margin expens percentag total revenu forecast sg expens percentag total revenu forecast despit gross margin miss expect oper margin y/i line expect strong sg expens control off-set gross margin weak cowen
compani report cowen compani
mm except yr organ fxpurchas account organ fx reiter report growth currenc organ exchang analyt core growth msd purchas account growth note food businessconst currenc note onesourc businessorgan stack basi embed assumpt growth total bit may conserv given food driver cyclic foreign exchang multispectr divestitur headwind quarter hsd organ reiter purchas account dx organ growth tradit organ growth currenc organ core growth exclud ei ei add core growth total ei grow y/i exchang cowen
compani report thomson eikon cowen compani
mm except yr cagrcommentsnet organ organ fx reiter tradit gross margin expans expect increas revenu gener sg expect increas revenu oper oper margin expans reiter non-oper interest interest/oth reiter earn tax rate per share reiter share share count slightli consensu except gross op cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
downsid risk includ limit macroeconom deterior
current level inabl execut integr eros market share price
due competit inabl deliv incremental/decrement margin target
value-destruct upsid risk includ limit better expect
revenue/ep disciplin buyer seller improv
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock thermo fisher scientif secur
cowen compani llc manag co-manag public offer past month
cowen compani llc receiv compens invest bank servic past month
past month client cowen compani llc cowen compani llc provid provid invest bank servic
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen cross-asset research due natur fix incom market issuer debt secur issuer discuss cowen cross-asset research report
assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon analysi reflect
analyst opinion date report expect continu analysi addit report relat issuer debt secur issuer
time time cowen cross-asset research analyst provid invest recommend secur subject report recommend intend
time date public within paramet specifi individu report cowen cross-asset research invest recommend made
strictli case-by-cas basi recommend provid part overarch rate system set consist appli benchmark view express
cross-asset research report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc juli et dissemin juli et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
